FDA Approved: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MYCAMINE (micafungin sodium) from Astellas Pharma US, Inc., expanding labeling through a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections Prophylaxis in Hematopoietic Stem Cell Transplantation Recipients
• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Mycamine (Micafungin)

Snippet

SUPPL AP for MYCAMINE (MICAFUNGIN SODIUM)